PARAMETRIC PORTFOLIO ASSOCIATES LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$455,000
+15.8%
2,098
-38.4%
0.00%
Q4 2020$393,000
+10.4%
3,408
-6.9%
0.00%
Q3 2020$356,000
-94.0%
3,662
-92.5%
0.00%
-100.0%
Q2 2020$5,972,000
+8.0%
48,664
-22.9%
0.01%0.0%
Q1 2020$5,530,000
+14.7%
63,152
+37.0%
0.01%
+25.0%
Q4 2019$4,820,000
+10.2%
46,095
+21.2%
0.00%0.0%
Q3 2019$4,375,000
+375.5%
38,036
+612.4%
0.00%
+300.0%
Q2 2019$920,000
+11.2%
5,339
+8.8%
0.00%0.0%
Q1 2019$827,000
+72.3%
4,907
-0.3%
0.00%
Q4 2018$480,000
-37.2%
4,924
+11.4%
0.00%
-100.0%
Q3 2018$764,000
+53.1%
4,422
+23.6%
0.00%
Q2 2018$499,000
+31.0%
3,579
+5.8%
0.00%
Q1 2018$381,000
-15.0%
3,384
-0.3%
0.00%
Q4 2017$448,000
+28.4%
3,393
-1.2%
0.00%
Q3 2017$349,000
+2.6%
3,434
+1.1%
0.00%
Q2 2017$340,000
-45.2%
3,395
-33.8%
0.00%
-100.0%
Q1 2017$621,000
+31.3%
5,132
+21.4%
0.00%0.0%
Q4 2016$473,000
-52.3%
4,229
-43.4%
0.00%0.0%
Q3 2016$991,000
-16.5%
7,470
-42.4%
0.00%
-50.0%
Q2 2016$1,187,000
+143.7%
12,963
+92.1%
0.00%
+100.0%
Q1 2016$487,000
+110.8%
6,747
+102.7%
0.00%
Q4 2015$231,000
-24.0%
3,3280.0%0.00%
-100.0%
Q3 2015$304,000
-25.7%
3,3280.0%0.00%0.0%
Q2 2015$409,000
+35.0%
3,3280.0%0.00%0.0%
Q1 2015$303,000
+34.7%
3,3280.0%0.00%
Q4 2014$225,0003,3280.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders